What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the current subscription status of Nidan Laboratories and Healthcare Limited IPO?

Nidan Laboratories and Healthcare Limited IPO has received a total subscription of 0.00 times overall.

IPO GreyPremiumLIVE

Grey Market Intelligence

Nidan Laboratories and Healthcare Limited

ListedSME

Healthcare · NSE

Incorporated in 2000, Nidan Laboratories and Healthcare Limited provides a wide range of diagnostic services including pathology, radiology, neurology, cardiology, and dental care. The company offers hundreds of routine and specialized pathology and radiology tests, covering everything from basic blood tests and X-rays to advanced molecular diagnostics, CT scans, and MRI scans, along with customized health packages and services like home sample collection and digital report delivery. Nidan operates diagnostic and collection centers under its brand, supported by its own appointment-booking mobile app and management software, partners with established pathology labs, employs over 200 people, and has received industry recognition for its diagnostic services.

Price Band

₹125

Issue Size

₹50.00 Cr

Lot Size

1000 shares

GMP

—

Est. Listing

₹125

at current GMP

Subscribed

—

Open

28 Oct 2021

2 Nov 2021

Allotment

9 Nov 2021

Refund

10 Nov 2021

Demat Credit

11 Nov 2021

Listing

12 Nov 2021

Last updated 12 days ago

Overview Live GMP Subscription Status Allotment Status Filing Documents

Overall Subscription

0.00x

Total Demand

QIB Multiplier

0.00x

Institutions & Funds

NII / HNI

0.00x

High Net-Worth

Retail (RII)

0.00x

Individual Bidders

Category-Wise Subscription Breakup

Live bidding breakdown by institutional, non-institutional, and retail investors

Total 0.00x

Category	Shares Offered	Shares Applied / Bid	Times Subscribed
Qualified Institutional (QIB)	2,000,000	—	0.00x
Non-Institutional (NII / HNI)	600,000	—	0.00x
Retail Individual (RII)	1,400,000	—	0.00x
Total	4,000,000	0	0.00x

Application-Wise Breakup

Total unique applications received across retail and HNI tranches

Apps 1.00x

Category	Applications Reserved	Applications Received	Times Subscribed
Retail (RII)	1,400	1,400	1.00x
HNIs (10L +)	9	9	1.00x
HNIs (2-10L)	43	43	1.00x
Total Applications	1,452	1,452	1.00x

Day-Wise Subscription Progress

Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.

About Nidan Laboratories and Healthcare Limited Public Issue & Market Profile

Nidan Laboratories and Healthcare Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹50 Crores. The shares are offered at a price band of ₹125 to ₹125 per equity share on NSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.

Bidding & Quota Instructions:

Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1000 shares (approx. ₹1,25,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.

Allotment Reconciliation Schedule:

Allotment reconciliation will be managed by Bigshare Services Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2021-11-11, while un-allotted funds or UPI block mandates will be released on 2021-11-10.

Frequently Asked Questions

What is Nidan Laboratories and Healthcare Limited IPO GMP today?

Currently, Nidan Laboratories and Healthcare Limited IPO Grey Market Premium (GMP) is not actively quoted or is quoted flat at ₹0. The shares are expected to list close to the issue price band of ₹125 to ₹125 per equity share.

What is the expected profit per lot for Nidan Laboratories and Healthcare Limited IPO?

The retail lot size is 1000 shares requiring a minimum application amount of ₹1,25,000. Expected listing price is ₹125 per equity share.

What is the issue size and price band for Nidan Laboratories and Healthcare Limited IPO?

The Nidan Laboratories and Healthcare Limited IPO aggregate issue size is ₹50 Crores with an equity price band set at ₹125 to ₹125 per equity share. The retail lot size is 1000 shares requiring a minimum capital outlay of approx. ₹1,25,000.

How can I check Nidan Laboratories and Healthcare Limited IPO live subscription demand?

Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 0.00x (Retail: 0.00x, QIB: 0.00x, NII: 0.00x). You can track live multiples directly on our dedicated subscription page.

Where and when will Nidan Laboratories and Healthcare Limited IPO allotment status be published?

The basis of allotment will be published on the official registrar portal (Bigshare Services Private Limited) and the BSE status verification website on or around 2021-11-09. Investors can verify status using PAN card or application number.

When is the listing date for Nidan Laboratories and Healthcare Limited IPO?

Nidan Laboratories and Healthcare Limited shares are scheduled to list on NSE on 2021-11-12.